Compounders Research Compare

Outset Medical, Inc.(OM)

Medical - Devices · San Jose, CA

$4.07-0.03 (-0.85%)

Delayed quote: Oct 6, 2026, 1:29 PM EDT

About Outset Medical, Inc.

Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.

San Jose, CA

310 employees

www.outsetmedical.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Leslie L. Trigg

View full financials

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T17:33:25.344Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:33:25.344Z.

Quote observation: 2026-10-06T17:29:53.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 75,353,881
Total debt · period ending 2026-06-30: 104,449,000
Cash · period ending 2026-06-30: 35,005,000
TTM free cash flow · period ending 2026-06-30: -38,879,000

FMP input reference: e005637c0728ee7719d987fd9d1ed1bb4b4a72c9577e4c0c1fad472fb0ddb1d0

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

OM EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

OM Competitors' EV/FCF Ratio

Outset Medical, Inc.

Current

Market Cap

$75.35M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Hyperfine, Inc.

Market Cap

$76.37M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SkinHealth Systems Inc.

Market Cap

$76.37M

EV/FCF Ratio

14.27x

TTM Avg

14.85x

3Y Avg

42.42x

5Y Avg

42.42x

Pulmonx Corporation

Market Cap

$77.08M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Sera Prognostics, Inc.

Market Cap

$77.53M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Inovio Pharmaceuticals, Inc.

Market Cap

$78.07M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Neonc Technologies Holdings, Inc.

Market Cap

$78.31M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Gain Therapeutics, Inc.

Market Cap

$71.23M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MindWalk Holdings Corp.

Market Cap

$71.19M

EV/FCF Ratio

N/A

TTM Avg

1223.62x

3Y Avg

1223.62x

5Y Avg

1223.62x

Citius Oncology, Inc.

Market Cap

$79.96M

EV/FCF Ratio

N/A

TTM Avg

816.68x

3Y Avg

816.68x

5Y Avg

816.68x

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Outset Medical, Inc. (OM)	$75.35M	N/A	N/A	N/A	N/A
Hyperfine, Inc. (HYPR)vs ›	$76.37M	N/A	N/A	N/A	N/A
SkinHealth Systems Inc. (SKIN)vs ›	$76.37M	14.27x	14.85x	42.42x	42.42x
Pulmonx Corporation (LUNG)vs ›	$77.08M	N/A	N/A	N/A	N/A
Sera Prognostics, Inc. (SERA)vs ›	$77.53M	N/A	N/A	N/A	N/A
Inovio Pharmaceuticals, Inc. (INO)vs ›	$78.07M	N/A	N/A	N/A	N/A
Neonc Technologies Holdings, Inc. (NTHI)vs ›	$78.31M	N/A	N/A	N/A	N/A
Gain Therapeutics, Inc. (GANX)vs ›	$71.23M	N/A	N/A	N/A	N/A
MindWalk Holdings Corp. (HYFT)vs ›	$71.19M	N/A	1223.62x	1223.62x	1223.62x
Citius Oncology, Inc. (CTOR)vs ›	$79.96M	N/A	816.68x	816.68x	816.68x

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

Free Cash Flow FCF Yield P/FCF Ratio EV/EBITDA All Metrics